Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2358-2367

  Tomita, Masayuki ^a   Sogabe, Hajime ^a   Nakazato, Shoko ^a   Nakatsuji, Shunji ^a   Noto, Takahisa ^a   Hamada, Kaori ^a   Kawachi, Hiroshi ^b   Shimizu, Fujio ^b   Matsuo, Masahiko ^a   Mutoh, Seitaro ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Anti Thy 1 antibody; Captopril; Mesangial proliferative glomerulonephritis; Predictors of renal outcome; Proteinuria

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE SIMULATION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAT; RAT STRAIN; UNINEPHRECTOMY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATININE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; MALE; NEPHRECTOMY; PHOTOMICROGRAPHY; PROTEINURIA; RATS;

EID: 27644485936     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi062     Document Type: Article

References (18)

1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748
2. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. Am J Med 2004; 116: 263-272
3. The GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349: 1857-1863
4. Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G. Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 2000; 35: 1155-1165
5. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial. Lancet 2003; 361: 117-124
6. Praga M, Gutierrez E, González E, Morales E, Hernández E. Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J Am Soc Nephrol 2003; 14: 1578-1583
7. Cheng QL, Orikasa M, Morioka T et al. Progressive renal lesions induced by administration of monoclonal antibody 1-22-3 to unilaterally nephrectomized rats. Clin Exp Immunol 1995; 102: 181-185
8. Nakamura T, Obata J, Kimura H et al. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999; 55: 877-889
9. Peters H, Martini S, Wang Y et al. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis. Kidney Int 2004; 66: 1434-1443
10. Ostendorf T, Kunter U, Gröne HJ et al. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2001; 12: 909-918
11. Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy. Nephron 2002; 90: 432-441
12. Peterson JC, Adler S, Burkart JM et al. Blood pressure control, proteinuria, and the progression of renal diseases. The modification of diet in renal disease study. Ann Intern Med 1995; 123: 754-762
13. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
14. Kawachi H, Orikasa M, Matsui K et al. Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol 1992; 88: 399-404
15. Mitch WE, Walser M, Buffington GA, Lemann JRJ. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2: 1326-1328
16. Matsumoto M, Tanaka T, Yamamoto T et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 2004; 15: 1574-1581
17. Naito T, Nitta K, Ozu H et al. Clinical assessment of the significance of platelet-derived growth factor in patients with immunoglobulin A nephropathy. J Lab Clin Med 1997; 130: 63-68
18. Eddy AA. Proteinuria and interstitial injury. Nephrol Dial Transplant 2004; 19: 277-281